Menarini announces new affiliates in Colombia and Peru

Family-controlled Italian drugmaker Menarini is consolidating its presence in Latin America with new affiliates in Colombia and Peru. Both countries have emerging economies which offer the company opportunities for market expansion with its high-quality, made-in-Italy pharmaceuticals.

"We are enthusiastic about increasing our presence in Latin America with the opening of our branches in Peru and Colombia, strategic countries where Menarini has decided to strengthen its commitment to guarantee that patients have access to extremely high-quality medicinal products manufactured at our 15 Menarini sites," explained Alberto Giovanni Aleotti, vice chairman of the Menarini Group. "This," he added, "represents a stepping stone for international growth of the group, which is currently present in over 130 countries, with its presence in the USA being a particularly notable success."

Menarini, which has a global annual turnover of 3.46 billion euros ($3.67 billion), says that 2017 opens with a new challenge for the Italian company which is specialized in medicinal products for pain relief and cardiovascular, respiratory, digestive tract and urological treatment and R&D into new cancer treatments.